Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07704216
What this trial is testing

Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 150
Testing effectiveness (Phase 2)WithdrawnNCT04025567
What this trial is testing

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Who this might be right for
Metastatic Hepatocellular CarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03893695
What this trial is testing

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

Who this might be right for
Metastatic Hepatocellular CarcinomaHCCCombinations of Drugs; Dependence
Suzhou Kintor Pharmaceutical Inc, 20
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Not applicableLooking for participantsNCT06876753
What this trial is testing

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 300
Early research (Phase 1)Study completedNCT00976170
What this trial is testing

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Hepatocellular Carcinoma
Chugai Pharmaceutical 42
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableStudy completedNCT05616039
What this trial is testing

I-FIGS Feasibility Study

Who this might be right for
Liver CancerHepatocellular CarcinomaLiver Metastasis Colon Cancer
University Hospital Plymouth NHS Trust 42
Early research (Phase 1)Study completedNCT02572687
What this trial is testing

Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaNon-Small Cell Lung Cancer+1 more
Eli Lilly and Company 85
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)WithdrawnNCT01953406
What this trial is testing

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLung Metastasis
Seoul National University Hospital
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableActive Not RecruitingNCT03432806
What this trial is testing

Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Who this might be right for
Colon CancerLiver Tumors
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT06553885
What this trial is testing

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Who this might be right for
Metastatic Colorectal CancerHepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT04791176
What this trial is testing

Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC

Who this might be right for
Hepatocellular CarcinomaRadiotherapyLenvatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Testing effectiveness (Phase 2)UnknownNCT02184182
What this trial is testing

Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)

Who this might be right for
Liver Tumors
Azienda Ospedaliera di Padova 10
Not applicableUnknownNCT04730388
What this trial is testing

ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or

Who this might be right for
Advanced Hepatocellular Carcinoma
University Hospital, Brest 100
Testing effectiveness (Phase 2)Study completedNCT01743469
What this trial is testing

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Who this might be right for
Advanced or Metastatic Hepatocellular CancerAdvanced or Metastatic Ovarian CancerMetastatic Renal Cell Cancer+1 more
Ipsen 201
Next Page